Scientists have taken a major step toward mimicking nature’s tiniest gateways by creating ultra-small pores that rival the dimensions of biological ion channels—just a few atoms wide. The breakthrough ...

Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated Europe Genomic Cancer Panel and Profiling Market size by value at USD 2.62 billion in 2023. During ...

Retrotransposons are pivotal in human genome evolution, driving structural variation and regulatory innovation while influencing health and disease.

Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...

Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA ...

A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...

MedGenome has announced the launch of MetaSeq, an advanced blood test designed to support faster and more comprehensive detection of bloodstream infections (BSI). MetaSeq uses metagenomic ...

Twist Bioscience's Q1 growth was modest, due in large part to an air pocket in demand caused by a large NGS customer. Read why TWST stock is a Buy.

Introduction While pathogen genomics using next-generation sequencing (NGS) has been recommended by the WHO as an essential ...

I am the Co-founder and CEO of HaystackAnalytics, a life sciences deep-tech company working in clinical genomics. At Haystack ...

NEB's collaborative approach is built on close work with laboratory automation partners to automate, optimize and verify performance across a wide range of NEBNext products, including NEBNext ...